Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immatics NV (NQ: IMTX ) 11.88 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 11.88 Bid (Size) 4.760 (2) Ask (Size) 12.60 (1) Prev. Close 11.88 Today's Range 11.88 - 11.88 52wk Range 7.150 - 13.77 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Immatics Appoints Alise Reicin to Board of Directors Today 7:00 EDT From https://immatics.com/ Via GlobeNewswire Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024 July 18, 2024 From https://immatics.com/ Via GlobeNewswire Performance YTD +10.82% +10.82% 1 Month -1.00% -1.00% 3 Month +19.64% +19.64% 6 Month +6.07% +6.07% 1 Year -0.25% -0.25% More News Read More Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Via Talk Markets Why Immatics Shares Are Rising Today July 24, 2023 Via Benzinga Recap: Immatics Q1 Earnings May 16, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 24, 2024 Via Benzinga Immatics Announces First Quarter 2024 Financial Results and Business Update May 14, 2024 From https://immatics.com/ Via GlobeNewswire IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023 March 21, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 21, 2024 Via Benzinga Immatics Announces Full Year 2023 Financial Results and Corporate Update March 21, 2024 From https://immatics.com/ Via GlobeNewswire 10 Health Care Stocks Whale Activity In Today's Session March 18, 2024 Via Benzinga Immatics Announces Pricing of $175 Million Public Offering January 17, 2024 From https://immatics.com/ Via GlobeNewswire Immatics Announces Proposed Public Offering January 17, 2024 From https://immatics.com/ Via GlobeNewswire Immatics Announces Third Quarter 2023 Financial Results and Business Update November 14, 2023 From https://immatics.com/ Via GlobeNewswire Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial November 08, 2023 From https://immatics.com/ Via GlobeNewswire Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy October 24, 2023 From https://immatics.com/ Via GlobeNewswire Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics September 11, 2023 Via ACCESSWIRE Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics September 11, 2023 From https://immatics.com/ Via GlobeNewswire Immatics Announces Second Quarter 2023 Financial Results and Business Update August 17, 2023 From https://immatics.com/ Via GlobeNewswire Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors August 10, 2023 From https://immatics.com/ Via GlobeNewswire Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb July 24, 2023 From https://immatics.com/ Via GlobeNewswire Top 5 Health Care Stocks That May Crash This Month June 22, 2023 Via Benzinga Immatics Announces First Quarter 2023 Financial Results and Business Update May 16, 2023 From https://immatics.com/ Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session May 02, 2023 Via Benzinga What's Going On With Immatics Shares Today May 02, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
